Clinical Trials Cultivation Environment 
Cannabis Law Report
OCTOBER 6, 2021
NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. About Flora Growth Corp.
Cannabis Law Report
AUGUST 19, 2021
Faced with booming sales, professor Sagnik Bhattacharyya, who researches psychotic and substance abuse disorders at King’s College London, says clinical trials are needed. “We have real expertise in cultivation and extraction in this country,” she added in a report published by drug reform group Volteface.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MARCH 29, 2022
Greenfern’s values are very much aligned with B Corp philosophies – our non-negotiable pillars of operating sustainably with people and the environment are in the forefront of our mind,” said Greenfern managing director Dan Casey. According to Greenfern, it achieved an overall finalised score of 86.8.
Cannabis Law Report
MAY 29, 2022
A new cultivation facility that is hoping to change lives with psychedelic mushrooms had their grand opening on Friday in Princeton, after being awarded a dealer’s license in February by Health Canada. The team has been focused on creating an environment that can be perfectly controlled for production. Optimi Health Corp.
MMJ Recs
JULY 11, 2024
Poor sleep hygiene practices, such as irregular bedtime routines, excessive screen time before bed, and an unsuitable sleep environment (e.g., Sleep hygiene practices, such as maintaining a consistent sleep schedule, creating a conducive sleep environment (e.g., excessive noise or light), can also disrupt the natural sleep-wake cycle.
Cannabis Law Report
SEPTEMBER 1, 2019
By early 2016, Australia’s federal parliament passed a bill that laid the groundwork for cannabis to be legally cultivated and manufactured for medicinal and scientific purposes here. We found the environment to be positive and supportive.”. The clinical trials and the standard of production could lead the world.”.
Cannabis Law Report
JULY 30, 2019
The consultation covers proposed licensing, cultivation, manufacturing and product standards, and a prescription and enforcement regime. But even if there is no doubt that a regulated market would provide a safer environment for access, we argue that there could be a potential cost to patient safety.
Expert insights. Personalized for you.
40 
Let's personalize your content